The research team in BITS Pilani Hyderabad campus which is working in the area of drug discovery, has received support from the Support Program for Scientific and Technological Cooperation between trilateral India, Brazil and South Africa (IBSA), funded by Department of Science and Technology (DST), India for their work in the area of a revolutionary anti-HIV drug.
BITS-Pilani, Hyderabad campus is one among the four top-of-the-line universities globally to receive this support.
Using their expertise and knowledge in the area, professors Dr Sriram and Dr P Yogeeswari have contributed to the drug design.
This project is aimed at coordinating the expertise in drug design, synthesis, natural product-based design, biochemists and medical professionals to come up with a novel anti-HIV drug.
The revolutionary project was initiated through an invitation by the South African research team who coordinated with Brazilian scientists to apply for a possible fund, “We are extremely proud of our faculty members who have been recognized for their expertise and knowledge through this global research grant.
At BITS Pilani, our faculty are constantly involved in cutting edge research and innovation both independently and with the support of the Industry and we are hopeful that this research into an anti-HIV drug would help in the arrest of the AIDS epidemic,” said Prof B N Jain, vice chancellor of BITS Pilani.
Jain said that as part of this initiative, the professors at BITS-Pilani are also simultaneously collaborating in the fields of medicinal chemistry and biochemistry with the research groups from Brazil and South Africa Federal University of Para, Brazil and the University of Kwa Zulu Natal, South Africa.
BITS-Pilani, Hyderabad campus is one among the four top-of-the-line universities globally to receive this support.
Using their expertise and knowledge in the area, professors Dr Sriram and Dr P Yogeeswari have contributed to the drug design.
This project is aimed at coordinating the expertise in drug design, synthesis, natural product-based design, biochemists and medical professionals to come up with a novel anti-HIV drug.
The revolutionary project was initiated through an invitation by the South African research team who coordinated with Brazilian scientists to apply for a possible fund, “We are extremely proud of our faculty members who have been recognized for their expertise and knowledge through this global research grant.
At BITS Pilani, our faculty are constantly involved in cutting edge research and innovation both independently and with the support of the Industry and we are hopeful that this research into an anti-HIV drug would help in the arrest of the AIDS epidemic,” said Prof B N Jain, vice chancellor of BITS Pilani.
Jain said that as part of this initiative, the professors at BITS-Pilani are also simultaneously collaborating in the fields of medicinal chemistry and biochemistry with the research groups from Brazil and South Africa Federal University of Para, Brazil and the University of Kwa Zulu Natal, South Africa.
0 comments
Post a Comment